Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
A Study of PCI-32765 (Ibrutinib) in Patients with Refractory Follicular Lymphoma Estudio de PCI-32765 (Ibrutinib) en pacientes con Linfoma Folicular refractario
The primary objective of the study is to evaluate the ORR of PCI-32765, as assessed by the Independent Review Committee (IRC), in subjects with chemoimmunotherapy-resistant FL El objetivo princi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Janssen-Cilag International NV Clinical Trial
Update Il y a 4 ans
A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of single ascending doses as well as repeated doses of JNJ-42165279 in healthy male participants.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag N.V./S.A
Update Il y a 4 ans
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
The purpose of this study is to evaluate the outcome of medication discontinuation, the safety and effectiveness of re-initiating risperidone long acting injection (RLAI) in case of relapse (the retur...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Janssen Alzheimer Immunotherapy
Update Il y a 4 ans
Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients Who are Apolipoprotein Eε4 non-carriers
Primary Objective and Endpoints To demonstrate the efficacy of multiple doses of IV-administered bapineuzumab (bapineuzumab IV; 0.5- and 1.0-mg/kg) compared to placebo in subjects with mild to mode...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Update Il y a 4 ans
A Double-Blind, Multiple Dose Titration Study to Investigate the Safety, Tolerability and Pharmacokinetics of Once Daily and Twice Daily Doses of JNJ-37822681 in Male and Female Patients With Stable Schizophrenia Protocol 37822681SCH2003; Phase IIa EudraCT Number: 2007-007669-20
The primary objective is to investigate the safety and tolerability of JNJ-37822681 administered as qd or bid following a dose titration in male and female patients with stable schizophrenia.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression Estudio para evaluar la eficacia, seguridad y tolerabilidad de dosis flexibles de esketamina intranasal más un antidepresivo oral en sujetos adultos con depresión resistente al tratamiento
The primary objective of this study is to evaluate the efficacy of switching adult subjects with TRD from a prior antidepressant treatment (to which they have not responded) to flexibly dosed intranas...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
Safety of Rivaroxaban in patients with nonvalvular atrial fibrillation who undergo catheter ablation
The primary objective is to evaluate the safety of rivaroxaban and uninterrupted vitamin K antagonist (VKA) in adult subjects with nonvalvular atrial fibrillation (NVAF) who undergo catheter ablation ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants with Previously Treated Indolent Non-Hodgkin Lymphoma
The primary objective of this study is to evaluate whether the addition of ibrutinib to bendamustine and rituximab (BR) combination or rituximab, cyclophosphamide, doxorubicin, vincristine, and predni...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JNJ-39588146 in Subjects with Heart Failure Uno studio randomizzato, in doppio cieco, controllato con placebo, a gruppi paralleli per studiare la sicurezza, la tollerabilita`, la farmacodinamica e la farmacocinetica di JNJ-39588146 in soggetti con insufficienza cardiaca
Assess the hemodynamic effects, the safety and the tolerability of JNJ-39588146 when administered by intravenous infusion to male subjects and female subjects of non-childbearing potential with New Y...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Janssen
Update Il y a 5 ans
Étude 54179060CLL3011-GLOW : étude de phase 3 randomisée comparant l’efficacité et la tolérance de l’ibrutinib en association avec du venetoclax par rapport au chlorambucil en association avec de l’obinutuzumab comme traitement de première ligne chez des patients ayant une leucémie lymphoïde chronique ou un lymphome à petits lymphocytes.
La leucémie lymphoïde chronique et le lymphome à petits lymphocytes sont des maladies cancéreuses du sang qui se distinguent par une multiplication incontrôlée de certaines cellules du système immunit...
Country
France
organs
Leucémies chroniques
,
Lymphomes non hodgkinien
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
,
Chimiothérapie
Essai ouvert aux inclusions
More information
Previous
12
13
14
15
16
17
18
19
20
21
Next